Concepedia

Guilherme Pessoa-Amorim

GP

Statistics

Publications

19

Citations

2.5K

H-Index

17

Active since

2017

Affiliations

University of Oxford(Current)

University of Bristol

Oxford University Hospitals NHS Trust

University of Nottingham

University of Manchester

Guilherme Pessoa-Amorim is an author at University of Oxford specializing in pharmacotherapy, medicine, and primary outcome analysis.

Publications per year

2017–2025

19

Publications

19

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology

Guilherme Pessoa-Amorim, C Fielder Camm, Parag Gajendragadkar et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2020 · 328 citations · Full text

Medicine, Cardiology, Clinical Cardiology +8

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

Peter Horby, Guilherme Pessoa-Amorim, Leon Peto et al. · medRxiv · 2021 · 328 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

1–5 of 19